Inhaled cannabis for chronic neuropathic pain: an individual patient data meta-analysis - The Journal of Pain

abstract
 

Highlights

• •Inhaled cannabis appears to provide short term relief from chronic neuropathic pain for one in five to six patients treated.
• •Our novel Bayesian hierarchical model allowed the synthesis of all available patient data from five RCT with disparate design and outcome reporting.
• •Pragmatic long term studies are needed to confirm the safety and effectiveness of inhaled cannabis for chronic neuropathic pain in the community.